Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)

v2.4.0.8
Note 2 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)
9 Months Ended
Sep. 30, 2013
Policies  
Fair Value of Financial Instruments

Fair Value of Financial Instruments:

 

In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for

measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities.  The Company adopted the

standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “ Fair Value Measurements and Disclosures ” (ASC 820) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

 

Level 1—Unadjusted quoted prices in active markets that are accessible at the measurement date for  identical, unrestricted assets or liabilities.

 

Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability; either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g. interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3—Inputs that are both significant to the fair value measurement and unobservable.

 

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments.  These financial instruments include investments in available-for-sale securities and accounts payable and accrued expenses.    The Company has also applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.

 

Investments:

 

The Company's loans, net of participations  and  any unearned discount, are considered investments under the 1940 Act and  are recorded at fair value. Since no ready market exists for these loans,  the fair value is determined in good faith by the Board of Directors. In  determining the fair value, the Company and Board of Directors consider factors such as the financial condition of the borrower, the adequacy of the collateral and individual credit risks.

 

Investments   in   equity   securities  are  recorded  at  fair  value, represented  as  cost,  plus  or   minus   unrealized  appreciation  or depreciation,  respectively. The carrying values  of  investments  that have no readily-determinable  market values are determined by the Board of Directors, based upon its analysis of the assets and revenues of the underlying invested companies.

                                                                                                                                                        

Because  of  the  inherent uncertainty  of  valuations,  the  Board  of Directors' estimates  of  the  values  of  the  investments  may differ significantly  from  the  values that would have been used had a  ready market  for  the investments  existed  and  the  differences  could  be material.